Book Cataloging Data CIP

Domestic

Chapter 44

1. Angiotensin-converting enzyme inhibitors can slow the progression of renal failure.

From Book Cataloging Data CIP · Read time 12 min · Updated March 22, 2026

Keywords专著资料, 全文在线浏览, 二、国内

Section Index

  1. Domestic
  2. Statins Can Treat Heart Failure – January 17, 2007
  3. Eradicating Helicobacter pylori can markedly reduce the risk of gastric cancer – January 20, 2007
  4. Sympathetic Nerves and Kidney Disorders – January 26, 2007
  5. Sorafenib Launched – January 26, 2007
  6. Tylenol: Trusted for 60 Years – January 29, 2007
  7. Severe Infections and Shock – January 29, 2007
  8. The 1918 Flu Pandemic – February 5, 2007
  9. Three Important Discoveries – February 8, 2007
  10. HBV Resistance to Nucleoside Analogs – February 12, 2007
  11. Targeted Therapy Briefing – March 5, 2007
  12. New Strategies for Hepatitis B Treatment – March 5, 2007
  13. Briefing – March 29, 2007
  14. ARB’s Cardiorenal Protective Effects – April 4, 2007
  15. Minutes from the 29th San Antonio Breast Conference – April 16, 2007
  16. Clinical Progress in Molecular Targeted Therapy for Hepatocellular Carcinoma – April 20, 2007
  17. New Developments in Chronic Gout – April 20, 2007
  18. Advances in the Treatment of Behçet’s Disease – April 20, 2007
  19. Megaloblastic Anemia – April 20, 2007
  20. The Mucosal Pathogenic Role of Helicobacter pylori – April 22, 2007
  21. Stress Ulcers – April 24, 2007
  22. The Role of Gastrin – April 26, 2007
  23. Respiratory Syncytial Virus Infection in Elderly Patients – April 28, 2007
  24. Invasive Fungal Infections – April 29, 2007
  25. Research Progress on Chronic Pancreatitis – April 30, 2007
  26. Nanotechnology: A Brief Discussion – May 14, 2007
  27. New Insights into Chronic Obstructive Pulmonary Disease – May 21, 2007
  28. References
  29. Cardiovascular and Cerebrovascular Diseases
  30. Respiratory Diseases
  31. Digestive Diseases
  32. Urological and Reproductive Disorders
  33. Blood Disorders
  34. Endocrine Disorders
  35. Metabolic Disorders
  36. Immunological Disorders
  37. Neurological and Psychiatric Disorders
  38. Bone and Joint Disorders
  39. Oncology in Various Fields
  40. Pediatrics
  41. Gynecology
  42. Otolaryngology
  43. Dermatology
  44. Traditional Chinese Medicine Theory
  45. Classical Works of Traditional Chinese Medicine
  46. Medical Talks and Medical Cases
  47. Traditional Chinese Medicine Formulas and Herbs
  48. Dan Fang Yan Fang
  49. Xi Yi Ji Chu
  50. Dan Fang Yan Fang
  51. Xi Yi Ji Chu

Domestic

  1. Angiotensin-converting enzyme inhibitors can slow the progression of renal failure.

  2. Wu Mengchao, a renowned liver surgery expert, was awarded China’s highest science and technology award.

  3. The State Council issued regulations on HIV prevention and control.

  4. The Ministry of Health established guidelines for clinical applications of organ transplantation.

  5. A male patient in China underwent facial reconstruction surgery.

  6. In 2005, the top ten causes of death among urban and rural residents were announced:

  7. Chen Fengfu Zhen served as Director-General of WHO.

  8. A domestically produced HIV vaccine completed Phase I clinical trials.

  9. Residents of Beijing were infected by eating golden snails, and cases of roundworm infection occurred in Guangzhou.

  10. The first edition of the “China Vascular Disease Report” was released.

Statins Can Treat Heart Failure – January 17, 2007

Since the introduction of statin drugs in the 1980s—such as simvastatin, fluvastatin, pravastatin, atorvastatin, rosuvastatin, and lovastatin—statins have revolutionized lipid-lowering treatments, setting a new standard in the field. Recently, statin therapies have garnered renewed attention: they have proven highly effective in treating heart failure, significantly reducing mortality rates among middle-aged and elderly patients. The efficacy of statins in treating heart failure has become one of the most significant developments in medical science in recent years.

Eradicating Helicobacter pylori can markedly reduce the risk of gastric cancer – January 20, 2007

Helicobacter pylori is a major contributing factor to gastric cancer; animal experiments have shown that eradicating H. pylori can prevent the development of gastric cancer. Japan’s Yamagata Prefecture has a high incidence of gastric cancer and a high mortality rate; experiments conducted by Mabe et al. in this prefecture demonstrated that eradicating H. pylori from the human stomach is effective in preventing gastric cancer.

Sympathetic Nerves and Kidney Disorders – January 26, 2007

In patients with kidney disease, the sympathetic nervous system is often in an excited state. Chronic renal failure patients exhibit elevated plasma catecholamine levels, and muscle sympathetic nerve tension increases. Animal experiments have shown that when both kidneys are removed, muscle sympathetic nerve tension (MSNA) decreases significantly, indicating that the kidneys serve as the source of the sympathetic nervous system.

Sorafenib Launched – January 26, 2007

The U.S. Food and Drug Administration (FDA) has approved a new targeted therapy drug named sorafenib—a milestone achievement following Herceptin (for breast cancer), Iressa (for lung cancer), Rituxan (for non-Hodgkin’s lymphoma), and Gleevec (for chronic myeloid leukemia). Sorafenib, also known as多吉美, is primarily used for the treatment of renal cancer.

Tylenol: Trusted for 60 Years – January 29, 2007

Common colds are viral or bacterial infections limited to the nasal cavity and throat; 70–80% of cases are caused by viruses, while 20–30% are caused by bacteria. For 60 years, Tylenol has been the best-selling cold remedy globally. It contains a combination of acetaminophen, pseudoephedrine, dextromethorphan hydrobromide, and other active ingredients, offering both antipyretic and analgesic effects, as well as calming and cough-suppressing properties.

Severe Infections and Shock – January 29, 2007

Septic shock combined with multiple organ dysfunction syndrome (MODS) is currently a leading cause of death in ICU units, making it a critical focus in modern emergency care. The in-hospital mortality rate ranges from 20% to 63%, similar to the in-hospital mortality rate for acute myocardial infarction.

  1. Hemodynamic characteristics: Pulmonary circulation resistance increases, while systemic circulation resistance decreases, leading to systemic tissue ischemia and hypoxia.

  2. Diagnosis: Body temperature above 38°C; heart rate above 90 beats per minute; respiratory rate above 20 breaths per minute; PaCO2 > 32 mmHg (4.3 kPa); white blood cell count > 12,000 cells per cubic millimeter, or more than 10% of immature cells.

  3. SIRS (Systemic Infection).

  4. Poor organ and tissue perfusion, such as oliguria or acute respiratory distress.

The 1918 Flu Pandemic – February 5, 2007

At that time, the influenza virus triggered an exaggerated immune response; this flu pandemic was a typical manifestation of such an exaggerated reaction. Instead of protecting individual patients, the immune system actually became a major cause of death. New influenza outbreaks pose a tremendous threat to humanity.

Future research efforts should focus on how to address the potential exaggerated immune responses that may occur early in influenza infections.

Three Important Discoveries – February 8, 2007

  1. At the end of the Year of the Dog, a patient in the integrated Chinese-Western medicine ward developed chronic nephritis and renal failure, followed by sudden urticaria. I prescribed 10 g of ephedra, 10 g of cinnamon twig, 10 g of apricot kernels, 6 g of licorice, 6 g of fresh ginger, 4 jujubes, 30 g of raw gypsum, 15 g of white peony, 6 g of angelica, 12 g of windproof herb, 10 g of red peony, 15 g of white skin, 20 g of honeysuckle, 20 g of Forsythia, 6 g of black snake, 20 g of astragalus, 12 g of rehmannia, 6 g of cicada shell, 20 g of purple grass, 10 g of dandelion, and 10 g of gardenia, decocted in water and taken over 3 doses. Not only did the urticaria subside, but the patient’s renal function also improved compared to before.

  2. At the end of the Year of the Dog, a long-term patient with renal failure was treated with this formula and saw remarkable results: BUN decreased from 14.8 mmol/L to 10.2 mmol/L, Cr from 320 mmol/L to 260 mmol/L, and the patient’s overall condition improved significantly. Formula: 12 g of rehmannia, 6 g of cornelian cherry, 10 g of Chinese yam, 6 g of peony bark, 12 g of poria, 10 g of alisma, 10 g of cinnamon twig, 6 g of dried ginger, 10 g of rhubarb, 15 g of honeysuckle, 15 g of white snake tongue grass, 15 g of motherwort, 10 g of plantain, 20 g of salvia, 20 g of astragalus, 10 g of leeches (to be taken separately), 10 g of goji berries, 10 g of mulberry, decocted in water and taken regularly—patiently, with gradual effects, avoiding impatience; if one seeks quick results, the treatment will be ineffective.

  3. At the end of the Year of the Dog, Yang Qing had a fever for a week, but ceftriaxone and sulfadimethoxine intravenous drips were ineffective. Herbal remedies included ephedra, cinnamon twig, apricot kernels, licorice, raw gypsum, chuanxiong, angelica, asarum, qianghuo, windproof herb, honeysuckle, forsythia, dandelion, artemisia, turtle shell, zhimu, rehmannia, peony bark, and other herbs. After taking just one dose, the fever subsided, and his renal function improved significantly.

HBV Resistance to Nucleoside Analogs – February 12, 2007

It is well known that nucleoside analogs are currently essential medications in clinical treatment of hepatitis B, directly inhibiting HBV-DNA replication and thereby altering hepatic histological changes, slowing the progression of liver disease. These medications can be used at any stage of liver disease development. Some researchers previously believed that these drugs could eliminate the virus while sparing liver function; however, recent studies have completely refuted this view.

Targeted Therapy Briefing – March 5, 2007

Previously, we had gefitinib (for lung cancer), Herceptin (for breast cancer), Rituxan (for non-Hodgkin’s lymphoma), and Gleevec (for chronic myeloid leukemia); now we add sorafenib (for kidney cancer).

New Strategies for Hepatitis B Treatment – March 5, 2007

Recent data show that 5–10% of HBV infections become chronic, with 23% of chronic infections progressing to cirrhosis, and 4.4% developing hepatocellular carcinoma. Among chronic liver disease patients, the annual incidence of decompensated cirrhosis is 3%, while the cumulative incidence over 5 years reaches 16%. The 5-year mortality rates for chronic hepatitis B—both compensated and decompensated—range from 0–2%, 14–20%, and 70–86%, respectively. These mortality rates are closely related to the impact of HBV-DNA. Therefore, inhibiting HBV-DNA is a crucial step in preventing the onset and progression of this disease.

Briefing – March 29, 2007

  1. Xeloda: Also known as capecitabine, 0.15 g, taken twice daily for a 2-week course with a 1-week break, often combined with 75 mg docetaxel via intravenous infusion. On the first day of the 3-week treatment, the lungs and breasts were affected.

  2. Compound O-Ke Acid (Kaidong): This product is a compound formulation containing calcium leucine, calcium phenylalanine, calcium valine, calcium methionine, and six amino acids, exhibiting significant efficacy in addressing protein metabolism disorders caused by renal insufficiency. Dosage: Tid, 4–8 tablets, taken between meals, calculated based on an adult weighing 70 kg. Each tablet contains 0.63 g.

ARB’s Cardiorenal Protective Effects – April 4, 2007

It is well known that hypertensive patients face higher cardiovascular events. These events are largely attributable to the angiotensin system, whose increased activity undoubtedly poses specific risks to target organs such as the heart and kidneys. Therefore, ARBs (angiotensin I receptor blockers) can help protect these target organs. Experiments have shown that in the heart of patients with heart failure, the concentration of angiotensin II is higher than in normal cardiac blood levels, and the level of angiotensin II rises proportionally with the severity of heart failure.

In addition to angiotensin II, the expression levels of angiotensin-converting enzyme (ACE), gastrin, and angiotensin II receptors are also higher than in normal cardiac blood levels. Practical evidence shows that ACE inhibitors have only a moderate impact on RAS activity, whereas ARBs (angiotensin I receptor antagonists) offer a distinct advantage. Another aspect of ARB’s influence on cardiac remodeling is its role in regulating heart rate; therefore, ARBs can help prevent atrial fibrillation. They are also among the most effective drugs for preventing atrial fibrillation. Beyond that, ARBs also play an important role in managing diabetes.

Minutes from the 29th San Antonio Breast Conference – April 16, 2007

  1. Endocrine therapy: Although aromatase inhibitors (AI) have proven effective, they can ultimately lead to drug resistance and contribute to tumor progression. After non-steroidal AI drugs fail, second-line endocrine therapies such as fulvestrant and exemestane have proven effective.

  2. A common side effect of chemotherapy in breast cancer patients is amenorrhea; this side effect can even provide some therapeutic benefits for hormone-sensitive patients. Some studies used a regimen of goserelin plus tamoxifen or MFC therapy for premenopausal breast cancer patients, with 1034 patients participating. Most of the patients were in the menopausal phase; comparative results indicated that endocrine therapy remains effective for women in menopause.

Clinical Progress in Molecular Targeted Therapy for Hepatocellular Carcinoma – April 20, 2007

Primary liver cancer often exhibits low sensitivity to radiation and chemotherapy, resulting in poor therapeutic outcomes. Additionally, drug resistance genes (MDR-1) are frequently upregulated in liver cancer patients, and many liver cancer patients also suffer from cirrhosis, where impaired liver function reduces the effectiveness of radiation and chemotherapy treatments. In recent years, with advances in research on epidermal growth factor and vascular endothelial growth factor, various targeted therapies—including monoclonal antibodies and tyrosine kinase inhibitors (TKIs)—have emerged.

  1. Tyrosine kinase inhibitors: The first to be launched, Raf (tyrosine kinase inhibitors), was sorafenib—also known as omeprazole. Task output rules: Translate this markdown block from Chinese to English. Preserve markdown markers, links, and formatting. Keep headings and list structure unchanged. Return only the translated block.

Input: Lafin, which has a relatively broad anti-tumor effect.

  1. Anti-vascular endothelial growth factor drugs: The growth of cancer requires an abundance of vascular endothelium.

Growth factors play a crucial role in this process, as tumor expansion urgently needs a sufficient supply of nutrients via blood circulation. Bevacizumab is a type of artificial recombinant monoclonal antibody that has shown significant efficacy in treating advanced liver cancer.

  1. Anti-epidermal growth factor: The growth and proliferation of cancer cells are heavily influenced by epidermal cell growth; erlotinib is a representative drug in this category (inhibiting epidermal growth factor receptors), exhibiting notable therapeutic effects against various solid tumors, including non-small cell lung cancer, head and neck cancer, and breast cancer. Another representative drug is cetuximab. These two medications have shown promising results in the initial treatment of advanced liver cancer. Further clinical trials are still underway.

New Developments in Chronic Gout – April 20, 2007

The number of gout patients is steadily increasing; between 1990 and 2000, the incidence of gout in the United States rose by 80%. Among men over 30 and women over 50 in Canada, gout accounts for 2%; among men over 80, gout affects 10% of the population. The onset of gout is characterized by: ① younger ages; ② more severe cases.

A one-year follow-up study of 110 gout patients revealed that the number of individuals experiencing functional impairment due to joint swelling and pain continued to rise. Renal dysfunction was observed in 39% of the patients, while tophi represent a severe form of gout.

  1. Reducing uric acid levels and promoting its excretion are the best approaches to managing gout; the first-line medications include probenecid, benzbromarone, and allopurinol.

  2. Reducing uric acid production involves using allopurinol, which has side effects in 20% of cases, with allergic reactions occurring in 10% of patients. Therefore, these medications are currently considered to lack effective long-term benefits.

  3. The introduction of new medications offers hope for the treatment of gout.

① FT is a novel uric acid inhibitor, with liver function abnormalities being the primary side effects.

② Uric acid oxidase: Uric acid oxidase, specifically human uric acid oxidase derived from recombinant technology, is now available on the market in Europe and the United States.

③ Polyethylene glycol uric acid oxidase: Phase I clinical trials have been completed in the United States.

In conclusion, gout is a treatable condition, but do not assume that relief means cure. Adhering to a low-purine diet, avoiding alcohol—especially beer—and adopting a healthy lifestyle with regular exercise and proper sleep patterns are essential for managing gout. For tophi, the primary treatment should be uric acid-lowering medications, while ensuring adequate dosage and duration of treatment.

Advances in the Treatment of Behçet’s Disease – April 20, 2007

Behçet’s disease manifests as eye involvement (uveitis), oral lesions (mucosal damage), and skin lesions in the lower body.

  1. Interferon-α-2a (IFN-α-2a) is effective not only for localized lesions but also for other systemic conditions.

  2. TNF-α inhibitors: Currently, there are two types of tumor necrosis factor-α inhibitors used clinically: ① infliximab; ② etanercept.

  3. Immunomodulatory therapies: It has been proven that heat shock proteins can treat uveitis associated with Behçet’s disease, utilizing the B subunit of cholera toxin (CTB).

Megaloblastic Anemia – April 20, 2007

This type of anemia is caused by gastrointestinal disorders leading to impaired absorption of folic acid and vitamin B12. Key characteristics include severe anemia, sometimes accompanied by mild jaundice. Red blood cells appear giant and oval-shaped, with diameters exceeding 100 µm; serum levels of folic acid and vitamin B12 are both below 100 ng/mL—folic acid measured in mmol, while vitamin B12 is measured in µmol. Bone marrow shows signs of hyperplasia, with increased nuclear lobulation in granulocytes.

The Mucosal Pathogenic Role of Helicobacter pylori – April 22, 2007

This bacterium is a spiral-shaped, Gram-negative microorganism; it was previously known as Helicobacter pylori due to its curved morphology. This bacterium possesses three key characteristics:

  1. It resides beneath the gastric mucosa or at the base of gastric papillae, using flagella to move between papillae and even penetrate into cells.

  2. It secretes urease, converting urea in the stomach into ammonia. As a result, an ammonia cloud forms around the bacterial cells, which over time irritates the mucosa, first causing papillary reduction and subsequently leading to lesions in the gastrointestinal tract.

  3. It also produces proteases that break down mucin, contributing to ulcer formation; additionally, it generates immune-biological active substances that trigger local hypersensitivity reactions.

Given these three mechanisms, individuals positive for H. pylori are more likely to develop chronic gastritis, gastric ulcers, and gastric cancer compared to the general population.

Stress Ulcers – April 24, 2007

Acute infectious diseases, active autoimmune conditions, infections affecting multiple organs throughout the body, extensive burns, shock, post-major surgery, and prolonged hormone therapy can all lead to widespread erosion and bleeding of the gastrointestinal mucosa. The underlying mechanisms are as follows:

  1. Increased secretion of gastric acid and pepsin stimulates irritation of the gastric mucosa.

  2. Damage to the gastric mucosal barrier (reduced prostaglandin synthesis, increased thromboxane and leukotriene production).

  3. Ischemia caused by disseminated intravascular coagulation (DIC) within the gastric mucosa, resulting in shock-related ischemia.

The Role of Gastrin – April 26, 2007

① Stimulates cells to secrete gastric acid; ② Promotes glandular secretion of gastric enzymes; ③ Encourages peristalsis and increases emptying; ④ Reduces pyloric tension. These four functions highlight the critical role of gastrin in human digestive function. However, when there are issues with gastric, pancreatic, or biliary function, gastrin's activity often decreases significantly. In cases of pancreatitis, cholecystitis, or enteritis, any changes in gastric acid, pancreatic juice, or bile—all including alterations in their pathways—can affect gastrin secretion, leading to reduced levels. Conversely, in some cases, gastrin secretion may increase abnormally, such as when gastric acid levels are low or when parasympathetic nerves are overactive.

Respiratory Syncytial Virus Infection in Elderly Patients – April 28, 2007

This virus is commonly referred to as RSV, and it is often found in equal proportions among elderly individuals alongside influenza A viruses. However, current X-ray and imaging studies cannot distinguish between the two. According to a report by Walsh et al. in the United States, RSV typically causes more pronounced congestion in the nasal mucosa, with additional symptoms like wheezing and dry crackles heard during auscultation, though body temperature is often normal. X-rays also exhibit certain distinctive features: unilateral involvement with small patchy lesions.

Invasive Fungal Infections – April 29, 2007

According to global epidemiological reports from 1999 to 2003, Candida and Aspergillus infections showed a slight decline between 1999 and 2000, but experienced an increase between 2000 and 2003—particularly in Aspergillus infections, which saw a more significant rise. Amphotericin B, fluconazole, and caspofungin had response rates of 79%, 72%, and 74% respectively for candidiasis bloodstream infections. However, due to the high toxicity of amphotericin B, it is no longer widely used. At present, caspofungin is considered the most promising option.

Additionally, the choice of treatment duration is also important: patients treated within 12 hours had a mortality rate of less than 10%, while those treated for 48 hours had a mortality rate exceeding 30%. For invasive pulmonary Aspergillus infections, early treatment is particularly recommended. Some advocate for prophylactic treatment, but experts believe this approach is unnecessary, as it may lead to unintended toxic side effects in healthy individuals. Others suggest empirical treatment—when a patient experiences persistent high fever and antibiotics fail to provide relief. First, caspofungin should be chosen, as this medication has fewer toxic side effects. In summary, invasive fungal infections can be treated with preventive measures, empirical treatments, or early interventions; early treatment emphasizes the importance of starting treatment as soon as possible.

Research Progress on Chronic Pancreatitis – April 30, 2007

Chronic pancreatitis (CP) is characterized by progressive inflammation and fibrosis of the pancreas. Over time, this condition can lead to permanent structural and functional changes in the pancreas. Persistent abdominal pain, diarrhea, and severe impairment of pancreatic secretory function are common symptoms.

  1. The onset of CP is linked to genetic mutations; scholars generally agree that CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) is a key factor in causing these mutations. Recently, several other important mutation factors have been identified—but opinions remain divided and are largely based on individual perspectives.

  2. Diagnosis: Currently, there is no specific diagnostic method. Treatment also lacks specialized therapies.

Nanotechnology: A Brief Discussion – May 14, 2007

Nanometers are units of length, where 1 µm = 1 × 10⁻⁶ m. Particles with diameters ranging from 1 to 100 µm are known as nanoscale particles, situated at the intersection between macroscopic and microscopic scales. From the 1980s to the 1990s, nanotechnology made rapid strides, yielding unprecedented breakthroughs across industries, agriculture, and medicine. Yet opportunities and challenges often go hand in hand; recent research has shown that nanoscale particles, being ultrafine, can penetrate cellular structures at the molecular and atomic level. On one hand, detection agents manufactured using this technology allow us to observe details as fine as a single hair; simultaneously, these particles can reach deep into the blood-brain barrier, blood-placenta barrier, and skin barriers, smoothly entering the interior of bioactive substances and potentially disrupting normal physiological functions. Similarly, the metabolic products of nanoscale materials can also cause microscopic pollution in the body, posing significant risks.

New Insights into Chronic Obstructive Pulmonary Disease – May 21, 2007

Chronic Obstructive Pulmonary Disease, abbreviated as COPD, is a condition caused by multiple factors. It not only affects the lungs themselves but also impacts the function of multiple organs throughout the body, leading to organ degeneration, cellular senescence, and apoptosis—all of which are often rooted in tissue hypoxia. Of course, timely treatment can help reverse these systemic changes and slow the progression of the disease.

  1. In the past, COPD treatment focused on relieving airway obstruction. However, recent research has highlighted that the primary cause of airway obstruction lies in inflammation—a process that impairs the function of mucociliary clearance, hindering mucus removal and gas exchange, ultimately leading to emphysema. Once emphysema develops, pulmonary arterial hypertension arises, increasing right ventricular load, and the diagnosis of cor pulmonale becomes established. Consequently, systemic hypoxia occurs, and multiple organs begin to suffer from impaired function.

  2. Commonly used medications include: ① antibiotics; ② bronchodilators: a. anticholinergic medications; b. B2 receptor agonists—long-acting β2 receptor agonists such as salmeterol and formoterol, taken twice daily; c. sulfonamides: theophylline is a representative drug in this category; although it has been used for a long time, it remains a valuable tool, capable of both expanding the bronchi and improving airway ventilation. However, this medication can interact negatively with other drugs, such as antibiotics, narrowing the therapeutic window; d. inhaled corticosteroids: budesonide is the preferred choice. Oral glucocorticoids (ICS) are rarely used due to their long-term side effects.

**

References

Cardiovascular and Cerebrovascular Diseases

Ocular Vasculitis (167)

Sinoatrial Block Syndrome (111)

Unstable Angina Pectoris (VAP) and Acute Myocardial Infarction (AMI) (434)

Cerebral Vertebral Artery Atherosclerosis Leading to Meniere’s Disease (405)

Reconsidering Hypotension (218)

Dihong Sanjian Decoction for Hemiplegia (256)

Dihong Sanjian Decoction for Hemiplegia Following Cerebrovascular Accidents (356)

Headaches Caused by Arteriosclerosis (335)

Atrial Premature Beats (118)

Hypertension and Renal Arteriosclerosis (341)

Summary of Hypertension Treatment (262)

Why Does Hypertension Often Combine with Cholecystitis? (243)

A Case of Hypertension Combined with Arteriosclerosis (69)

Understanding and Treating Hypertension (367)

Gegen Tang for the Treatment of Arteriosclerotic Occlusive Disease (297)

Drug Infusion for Coronary Heart Disease (183)

Traditional Chinese Medicine Treatment for Coronary Heart Disease (437)

Premature Beatings (182)

Huayang Sanjian Decoction for Giant Cell Arteritis (198)

Acute Coronary Syndrome (392)

Acute Coronary Syndrome (ACS) (424)

Treatment of Acute Coronary Syndrome (496)

Key Clinical Treatment Points for Acute Myocardial Infarction… (404)

Intravenous CIK Infusion Can Reduce the Risk of Death from AMI (361)

Intravenous EpiPen for Severe Hypertension (161)

Papaverine for Stroke Hemiplegia (81)

Traditional Chinese Medicine Formulas for Chronic Viral Myocarditis (145)

Clinical Experiences in Treating Chronic Viral Myocarditis (185)

Chronic Stable Angina Pectoris (464)

Cerebral Hemorrhage or Cerebral Infarction – A Case Study (297)

Numbness in Hands, Shoulders, and Arms Caused by Cerebral Arteriosclerosis (94)

Sweating and Restlessness in Cerebral Arteriosclerosis (424)

Dizziness in Cerebral Arteriosclerosis (9)

Premature Contractions and Recollections (304)

Treatment Experience for Premature Contractions (26)

New Approaches to the Treatment of Ischemic Heart Disease (462)

Ruanmai Ling for the Treatment of Cerebral Arteriosclerosis (117)

Cure of Ventricular Premature Contractions (51)

Tongmai Decoction for Cerebral Thrombosis (83)

Three Cases of Pulseless Syndrome: Exploring Their Origins (198)

Understanding Cerebral Hemorrhage in the Cerebellum (387)

Treatment Experiences for Pericardial Effusion (214)

Atrial Fibrillation (97)

Emergency Medications for Myocardial Infarction (425)

Re-understanding Myocardial Infarction (AMI) (321)

Further Discussions on Angina Pectoris (121)

Treatment of Arrhythmias (248)

Treatment of Arrhythmias (146)

More on Heart Failure (498)

Treatment Experiences for Heart Failure (118)

Resuscitation for Cardiac Arrest (263)

Cardiac Load and Heart Failure Treatment (111)

The Significance of Autonomic Nervous System Disorders in the Diagnosis of Cardiac Disorders (399)

Thromboangiitis Obliterans (57)

The Relationship Between Lipids and Coronary Heart Disease (234)

Treatment of Hidden Coronary Heart Disease (441)

Pre-excitation Syndrome (230)

Primary Hypotension (192)

Revisiting TH+ABC for Acute Myocardial Infarction (416)

One Approach to Treating Chest Pain in Coronary Heart Disease (250)

Treatment of Premature Beatings (83)

Treatment of Heartbeat Palpitations (85)

Cure of a Case of Acute Exudative Pericarditis (197)

Zhi Gan Cao Tang for Coronary Heart Disease (414)

Stroke with Speech Impairment (298)

Experience in Treating Stroke (81)

Treatment of Severe Myocarditis (148)

Dizziness Caused by Vertebral Arteriosclerosis (408)

Hemiplegia and Aphasia Caused by Left Hemisphere Cerebral Infarction (226)

Respiratory Diseases

Misdiagnosis of Lung Infection in Three Cases of Lung Cancer (227)

Lung Fungal Infections (287)

Key Diagnostic Points for Pulmonary Tuberculosis (421)

Treatment of Pulmonary Tuberculosis (422)

Revisiting Pulmonary Embolism (417)

Liver Tuberculosis (477)

Traditional Chinese Medicine Treatment for Bronchial Asthma (108)

Treatment of Respiratory Infections (198)

Complications of Respiratory Failure (350)

Clinical and Therapeutic Aspects of Respiratory Failure (172)

Respiratory Failure Rescue (263)

Ji Xiang San for Pulmonary Edema (116)

Acute Upper Respiratory Tract Infection (CAP) (467)

My View on Interstitial Lung Disease (225)

Tuberculous Hemoptysis and Hemoptysis in Bronchiectasis ((6)

Respiratory Infection in Elderly Patients with Respiratory Syncytial Virus (539).

Ling Gui Zao Gan Tang for Bronchial Asthma Combined with Allergic Colitis (220)

Respiratory Failure in Chronic Lung Disease (349)

Diagnosis and Treatment of Chronic Cough (494)

Chronic Bronchitis and Emphysema (33)

Chronic Pharyngitis-Related Cough (381)

Acute Pharyngitis Triggering Cough (334)

Chronic Pharyngitis (309)

Chronic Pharyngitis-Related Coughing (323)

Acute Exacerbations of Chronic Obstructive Pulmonary Emphysema and Cor Pulmonale (420)

Diffuse Panbronchiolitis (180)

Upper Airway Drooling Syndrome (508)

Eosinophilic Bronchitis (370)

Experienced Treatments for Stubborn Asthmatic Bronchitis (79)

Good News for Asthma Patients (512)

Further Discussions on Bronchial Asthma (204)

Related Materials on Bronchial Asthma (487)

Digestive Diseases

Treatment of Atrophic Gastritis (131)

Hydatid Disease (286)

Differential Diagnosis of Viral Hepatitis (130)

Brief Notes on Viral Hepatitis (161)

Chai Hu Gui Zhi Gan Tang for Abdominal Distension (104)

Irritable Bowel Syndrome (232)

Irritable Bowel Syndrome (IBS) (479)

Irritable Bowel Syndrome (337)

High-Dose Albumin Therapy for Hepatorenal Syndrome (361)

Experience in Resuscitating a Case of Massive Blood Loss and Liver Coma Due to Massive Blood Transfusion (167)

Analysis of Benign Biliary Diseases (105)

Post-Cholecystectomy Syndrome (164)

Bile Reflux Gastritis (444)

One Case of Liver Disease (140)

Another Treatment for Liver Disease (456)

Treatment of Liver Coma (132)

Treatment of Liver Pain (340)

Treatment Experiences for Liver Pain After Hepatitis (152)

Microcirculatory Manifestations in Liver Cirrhosis Following Hepatitis (331)

Another Treatment for Hepatitis (36)

Re-Recognition of Stomach Pain in Liver Cirrhosis Patients with Ascites (334)

Complications in Liver Cirrhosis Patients with Ascites (245)

Electrolyte Imbalances in Liver Cirrhosis with Ascites (303)

Gastric Symptoms in Liver Cirrhosis with Ascites (328)

Another Treatment for Liver Cirrhosis with Ascites (153)

Treatment Experiences for Liver Cirrhosis Patients with Darkened Facial Complexion (340)

Treatment of Ruptured Esophageal Varices in Liver Cirrhosis (213)

Treatment of Liver Cirrhosis with Yellowing (379)

Rare Complications of Liver Cirrhosis (225)

Traditional Chinese Medicine Infusions for Liver Cirrhosis (152)

Another Treatment for Liver Cirrhosis (380)

Ge Xia Zhu Yu Tang for Ulcerative Colitis · (59)

Pathogenicity of Hepatitis G (373)

Functional Dyspepsia (HD) (495)

Treatment Experiences for Hepatitis G (63)

Reconsidering the Role of Yellowing (317)

Huang Lian Jie Du Tang’s Anti-Ulcer Effects (138)

Treatment of Atrophic Gastritis with Blood-Activating and Stasis-Resolving Formulas (117)

Treatment of Atrophic Gastritis with Blood-Activating and Stasis-Resolving Formulas (115)

Treatment Experiences for Acute Cholecystitis (53)

Treatment of Functional Dyspepsia with Anti-Helicobacter Pylori Infection (339)

Crohn’s Disease (231)

Crohn’s Disease and Ulcerative Colitis (476)

Reconsidering the Incidence and Treatment of Ulcerative Disease (338)

On Chronic Pancreatitis (7)

Treatment of Chronic Cholecystitis (184)

Treatment of Chronic Colitis (52)

General Overview of Chronic Gastritis (267)

Another Treatment for Chronic Pancreatitis (406)

Chronic Pancreatitis and Fatty Liver ((355)

Reconsidering Chronic Pancreatitis (275)

Re-Recognizing Chronic Pancreatitis (275)

Re-Discussing Chronic Pancreatitis (248)

Chronic Pancreatitis and Total Biliary Stricture (395)

Another Treatment for Chronic Hepatitis B Prevention and Control (370)

Surgical Treatment of Portal Hypertension (191)

Microcirculatory Dysfunction of the Gastric Mucosa in Portal Hypertension (343)

Oyster Powder for Ulcerative Disease (52)

Treatment of Prolonged Hepatitis (66)

Japanese Anzhong Powder for Ulcerative Disease (127)

Triple-Drug Combination for H. pylori (529)

Upper Abdominal Discomfort and Complaints (297)

Emergency Management of Upper Gastrointestinal Bleeding (372)

Treatment Experiences of Director Feng from the Provincial Academy of Agricultural Sciences for Fatty Liver (405) Task output rules: Translate this markdown block from Chinese to English. Preserve markdown markers, links, and formatting. Keep headings and list structure unchanged. Return only the translated block.

Input: Food Stomach Vein Rupture Massive Hemorrhage Treatment (187)

Discussion on Recurrence of Chronic Hepatitis (13)

Discussion on Hepatitis B (95)

Atrophic Gastritis with Intestinal Metaplasia (116)

Sclerotherapy for Variceal Gastroesophageal Veins (177)

Pharmacological Treatment of Gastroesophageal Reflux Disease (GERD) (490)

Experience in Treating Stomach Pain (418)

Brief Discussion on Stomach Pain Treatment (49)

Treatment of Epigastric Pain (332)

Wu-Ong Decoction for Ulcerative Colitis (53)

Re-understanding of Hepatitis E (401)

Xiang Su San for Allergic Intestinal Syndrome (139)

Small Intestine Failure (523)

Pancreatitis and Biliary Ascariasis (352)

Attempts to Convert Hepatitis B Surface Antigen to Negative (302)

Hepatitis B Incidence (115)

Current Status of Hepatitis B Treatment (362)

Another Achievement in Hepatitis B Treatment (270)

Yi Gui Tong Yuan for Liver Diseases and Sha Shen Mai Men Dong Tang for Stomach Diseases (331)

Treatment of Hepatitis B Viral Infection (363)

Antiviral Therapy for Hepatitis B (476)

Jun Yu Lan Gen Tang for Chronic Liver Disease (33)

Stress Ulcers (539)

Stress Ulcers (346)

Invited Consultation at the Affiliated Hospital of Qinghai Medical College – Treatment of Liver Cirrhosis with Ascites (Patient: Minister Ye of the United Front Work Department of Qinghai Province) (216)

Helicobacter pylori (496)

Helicobacter pylori and the Duodenum (166)

Cholestatic Liver Cirrhosis (493)

One Approach to Liver Treatment (289)

Experience in Treating Liver Area Pain (31)

Experience in Treating Liver Cirrhosis with Ascites – Water-Reducing Formula (133)

Severe Hepatitis with Hepatic Coma (224)

Pathogenesis and Treatment of Severe Hepatitis (164)

Rescue Treatment for Severe Hepatitis (452)

Urological and Reproductive Disorders

Benign Membranous Nephropathy (178)

Treatment Experience for Ammonia Hyperemia (76)

Non-Gonococcal Urethritis (335)

Non-Gonococcal Urethritis (359)

Acute Renal Failure (433)

Acute Renal Failure (373)

One Approach to Acute Nephritis (135)

Experience in Reducing Proteinuria (37)

Introduction to Experience in Treating “Proteinuria” (90)

Treatment of Hydrocele (25)

Experience in Treating Chronic Nephritis Before 1995 (209)

Senile Urinary Abnormalities (296)

A Brief Discussion on Traditional Chinese Medicine Treatment of Chronic Nephritis (3)

Secondary Hyperparathyroidism in Chronic Renal Failure (338)

Treatment of Chronic Renal Failure (453)

Chronic Nephritis (506)

A Case of Chronic Nephritis (22)

Another Treatment Experience for Chronic Nephritis (205)

New Insights into Chronic Nephritis (311)

Another Approach to Chronic Nephritis (207)

Another Approach to Chronic Nephritis (451)

Treatment of Chronic Nephritis (268)

Treatment of Chronic Nephritis (71)

Traditional Chinese Medicine Treatment of Chronic Nephritis (249)

One Approach to Chronic Nephritis Treatment (351)

Treatment Experiences for Chronic Nephritis (353)

Urinary Calculi (191)

Treatment of Diabetes Insipidus (199)

Urological Treatment for Non-Gonococcal Urethritis (283)

A Brief Discussion on Prostate Issues (401)

Prostatitis – A Single Approach (55)

San Cai Feng Sui Dan with Modifications for Ejaculation and Sleeplessness (79)

Treatment Experiences for Nephrotic Syndrome (204)

Treatment Experiences for Renal Failure (358)

Coagulation and Inflammation in Nephritis (169)

Treatment of Nephritis Complicated by Azotemia (190)

Another Case of Nephritis with Hematuria (135)

A Single Approach to Nephritis (90)

A Case of Nephritis (67)

One Approach to Nephritis Treatment (92)

Summary of Traditional Chinese Medicine Treatment for Nephritis (208)

Sheng Jing Wan for Male Infertility (203)

Shou Wu Huang Jing Tang for Sperm Reduction and Infertility (284)

Vermifuge for Chronic Nephritis and Renal Dysfunction (249)

On the Treatment of Urinary Obstruction (43)

Treatment of Chronic Renal Failure (259)

Treatment Experiences for Hematuria (333)

Treatment Experiences for Yang Qiang Bu Dao (240)

Treatment Experiences for Erectile Dysfunction – One Case (302)

Treatment Experiences for Itching in the Vagina (240)

Yu Lin Zhu for Infertility Due to Cold in the Uterus (67)

Evening Primrose Oil for Experimental Chronic Renal Failure ((176)

Further Discussion on Nephritis Treatment (88)

Treatment Experiences for Chronic Nephritis (76)

Prostatitis Formula (77)

Summary of Hematuria Treatment (30)

Traditional Chinese Medicine Treatment for Fungal Vaginitis (344)

Blood Disorders

Leukemia with Elevated White Blood Cell Count · (169)

Overview of Leukemia (508)

A Case of Fever Associated with Leukemia (67)

A Case of Fever Resolution in Leukemia (61)

Western Medical Combined Treatment Plans for Leukemia (37)

Traditional Chinese Medicine Treatment of Leukemia (68)

Monoclonal Antibody Therapy for Malignant Blood Disorders (113)

Re-understanding of Multiple Myeloma (MM) (300)

The Effect of Gui Zhi Fu Ling Wan on Disseminated Intravascular Coagulation Caused by Endotoxin (109)

Two Cases of Henoch-Schönlein Purpura (117)

Experience in Henoch-Schönlein Purpura (366)

Medication for Henoch-Schönlein Purpura (473)

Treatment of Henoch-Schönlein Purpura (183)

A Case of Acute Lymphocytic Leukemia (157)

Chemotherapy Regimens for Acute Leukemia (102)

Atypical Clinical Symptoms of Acute Leukemia (114)

Chemotherapy Regimens for Acute Leukemia (201)

Chemotherapy Combination Regimens for Acute Leukemia (178)

Acute Lymphocytic Leukemia (438)

One Approach to Lowering White Blood Cell Count (184)

Megaloblastic Anemia (538)

Elevated Basophil Levels in Patients with Chronic Myeloid Leukemia (234)

Another Approach to Chronic Myeloid Leukemia (153)

Treatment Experiences for Chronic Leukemia (54)

Chronic Myeloid Leukemia (508)

Another Approach to Chronic Myeloid Leukemia (154)

Acute Transformation in Chronic Myeloid Leukemia (188)

Prognosis of Chronic Myeloid Leukemia (155)

Chronic Lymphocytic Leukemia (307)

Hemolytic Anemia (177)

Hemolytic Anemia (HA) (446).

(A Brief Discussion on Hemolytic Anemia (185)

Porphyria (308

Thrombotic Thrombocytopenic Purpura – Hemolytic Uremic Syndrome (TTP-HUS) (346)

Two Cases of Thrombocytopenic Purpura (402)

Treatment of Thrombocytopenic Purpura (85)

Major Insights into Blood Disorder Treatment (343)

Clinical and Practical Aspects of Hemophilia (166)

Treatment of Aplastic Anemia (70)

Another Approach to Aplastic Anemia (336)

My Views on Aplastic Anemia (269)

Treatment of Aplastic Anemia (319)

A Brief Record of Aplastic Anemia Treatment (320)

Another Discovery in Aplastic Anemia Treatment (135)

Polycythemia Vera (308)

Insights into Aplastic Anemia Treatment (149)

Treatment Experiences for Purpuric Nephritis (397)

Endocrine Disorders

131I Therapy for Hyperthyroidism (407)

A Brief Understanding of Hyperthyroidism (114)

A Brief Discussion on the Diagnosis and Treatment of Hyperthyroidism (509)

Treatment Experiences for Hyperthyroidism (433)

Hyperthyroidism (54)

Treatment Experiences for Supraorbital Moles (430)

Adrenal Insufficiency (305)

Adrenal Cortex Insufficiency (74)

Adrenal Cortex Insufficiency (300)

Subacute Thyroiditis (233)

Traditional Chinese Medicine Treatment of Subacute Thyroiditis (134)

Subacute Thyroiditis with Multiple Systemic Lymphadenitis (398)

A Case of Subacute Thyroiditis (269)

Subacute Thyroiditis and Chronic Lymphocytic Thyroiditis (235)

Traditional Chinese Medicine Treatment of Subacute Thyroiditis (273)

Treatment of Goiter (35)

Myxedema Formula (122)

Myxedema and Heart Disease (397)

Metabolic Disorders

Type 2 Diabetes – A Brief Discussion ((395)

Hypokalemia (217)

Hypokalemia (234)

Hepatic Keshan Disease (256)

Traditional Chinese Medicine Treatment of Hepatic Keshan Disease (258)

Hyperuricemia (246)

Hyperkalemia (217)

Hyperkalemia (232)

Hyperlipidemia and Lipoproteinemia (277)

Iron Hematohyaline Deposits (289)

Traditional Chinese Medicine Treatment of Hyperthyroidism (27)

Osteoporosis in the Elderly (311)

Thiamine Deficiency (Beriberi) (325)

Re-understanding of Diabetes (325)

Re-understanding of Diabetes (445)

Diabetes with Peripheral Neuropathy (199).

(Diabetic Patients with Gastroparesis (444)

Diabetic Nephropathy and Blood Viscosity (338)

Diabetic Ketoacidosis (426)

Diabetes – One Approach (69)

Drug Treatment for Diabetes (396)

New Insights into Diabetes Treatment (277)

Diabetes Treatment Experiences (80)

One Approach to Diabetes Treatment (117)

Points to Note in Diabetes Treatment (481)

Treatment of Gouty Arthritis (21)

Clinical Diagnosis and Treatment of Gout (233)

Treatment of Gout (241)

Gout Treatment Experiences (56)

Niacin Deficiency (325)

Yu Quan Wan for Diabetes (77)

Immunological Disorders

Behçet’s Disease – One Approach (376)

Behçet’s Syndrome (26)

Allergic Septicemia (397)

Cantharidine Soup for Scleroderma (264)

Cholinergic Neuronal Blockade for Rheumatoid Arthritis (253)

Dang Gui Niang Tong Tang for Damp-Heat Erythema (85)

Experiences in Treating Persistent Low-grade Fever (97)

Lupus Erythematosus (59)

Treatment Methods for Lupus Erythematosus (140)

Necrotizing Cervical Lymphadenitis (230)

Connective Tissue Disease with Thrombophlebitis (232)

Connective Tissue Disease Treatment Experiences (197)

Sarcoidosis (446)

Overview of Sarcoidosis (443)

Sarcoidosis Treatment Experiences (150)

Nodular Arteritis and Large-Arteritis (235)

Nodular Arteritis (30)

Progressive Muscular Dystrophy (314)

Lupus Nephritis (SLE Kidney) (371)

A Brief Discussion on Rheumatoid Arthritis (450)

Rheumatoid Joints (480)

Rheumatoid Arthritis and Ankylosing Spondylitis (168)

Further Discussions on Rheumatoid Arthritis (474)

Treatment of Rheumatoid Arthritis (238)

Summary of Rheumatoid Arthritis Treatment (189)

Polymyositis – A New Perspective (241)

Wang Luqiu’s Experience in Treating Rheumatoid Arthritis (260)

Thrombophlebitis of the Lower Limbs in Systemic Lupus Erythematosus (412)

Systemic Lupus Erythematosus (256)

A Case of Systemic Lupus Erythematosus (261)

Drug Treatment for Systemic Lupus Erythematosus (510)

Another Key Point in Systemic Lupus Erythematosus Treatment (246)

Treatment Experiences for Septicemia (181)

Treatment of Sarcoidosis (75)

Reflections on Sarcoidosis Treatment (292)

Further Discussions on Rheumatoid Arthritis (158)

Myasthenia Gravis and Radiculitis (229)

Autoimmune Hepatitis (419)

Autoimmune Disorders (230)

Autoimmune Pancreatitis (473)

Current Status of Rheumatic Fever (344)

Treatment of Rheumatoid Arthritis (61)

Neurological and Psychiatric Disorders

Treatment Experiences for Insomnia (312)

New Therapies for Herpes Zoster (285)

Treatment Experiences for Single-Limb Paroxysmal Numbness (385)

A Case of Epilepsy (36)

Treatment of Epilepsy (150)

Traditional Chinese Medicine Treatment for Multiple Radiculitis (228)

Feng Yin Tang for Peripheral Nerve Disorders (495)

Infectious Radiculitis (178)

Guillain-Barré Syndrome (396)

Guillain-Barré Syndrome (GBS) (480)

Hu Qian Wan for Multiple Radiculitis (82)

Connective Tissue Disease Treatment Experiences (151)

Antipsychotic Medications (189)

Drug Treatment for Chronic Insomnia (481)

Important Risk Factors for Parkinson’s Disease (519)

Treatment of Headaches Using the “Wind-Dispelling and Heat-Clearing” Method (60)

Treatment of Insomnia (472)

Experience in Treating Limb Weakness (242)

Treatment of Idiopathic Tremor (266)

Further Discussion on Headaches (238)

Treatment of Headaches (237)

Treatment of Headaches – Don’t Forget to Strengthen Yang (80)

Traditional Chinese Medicine Treatment of Headaches (428)

Treatment Experiences for Insomnia due to Deficiency (85)

Treatment Experiences for Severe Autonomic Dysfunction (76)

Integrated Chinese and Western Medicine Treatment for Superior Sciatic Nerve Injury Syndrome (170)

Discussion on Traditional Chinese Medicine Treatment of Epilepsy (255)

Zi Shen Pian for Epilepsy (415)

Bone and Joint Disorders

Large Bone Resorption (162)

Fang Ji Huang Qi Tang with Ephedra for Osteoarthritis of the Knee (107)

Compound Ma Qian Zi Powder for Lumbar Disc Herniation (180)

Traditional Chinese Medicine Treatment of Osteomyelitis. ((181)

Bone Growth Pill (254)

Genetic Susceptibility to Joint Diseases. (518)

Jing Chui Ning Capsules for Cervical Spondylosis (139)

Headaches Caused by Stiff Neck (272)

Ma Qian Zi Powder for Intervertebral Disc Herniation (83)

Chronic Osteomyelitis (155)

Calcification of the Ligamentum Flavum in the Thoracic Vertebrae (486)

Main Clinical Manifestations of Lumbar Disc Herniation (191)

Treatment Experiences for Tuberculosis of the Lumbar Vertebrae with Cold Abscess (226)

Treatment of Intervertebral Disc Herniation (272)

Intervertebral Disc–Related Lumbar and Leg Pain (512)

Treatment of Heel Pain (83)

Treatment Experiences for Sciatica (58)

Treatment Experiences for Sciatica (185)

Oncology in Various Fields

Traditional Chinese Medicine Treatment for Cancer-Related Fever (167)

Chemotherapy for Nasopharyngeal Carcinoma (217)

High-Dose Cisplatin plus Sodium Thiosulfate for Pleural Effusion (441)

Three Cases of Multiple Hepatic Cysts (229)

Multiple Myeloma (246)

Malignant Histiocytosis (435)

Chemotherapy for Non-Small Cell Lung Cancer (497)

Internal Medicine Treatment for Lung Cancer (379)

Lung Cancer Chemotherapy (237)

Re-understanding of Lung Cancer (313)

Preliminary Exploration of Liver Cancer Formulas (143)

Further Exploration of Liver Cancer Formulas (146)

Clinical Use of Drugs for Liver Cancer (305)

Treatment of Liver Cancer (272)

Treatment Experiences for Liver Cancer (269)

Treatment of Liver Hemangiomas (381)

Inflammatory Pseudotumors of the Liver (201)

Eliminating Helicobacter pylori Can Significantly Reduce the Risk of Gastric Cancer (533)

Brief Information on Cervical Cancer (519)

Precursor Lesions of Cervical Cancer (528)

Bone Metastatic Cancer (313)

Treatment of Bone Metastatic Cancer (320)

Exploration of Bone Metastasis (279)

Malignant Mixed Tumor of the Submandibular Region (310)

Thyroid Cancer (274)

Treatment Experiences for Thyroid Cancer Pressing on Upper Limb Veins (416)

Traditional Chinese Medicine Treatment for Thyroid Cancer (273)

Treatment of Thyroid Adenoma (29)

Thyroid Nodules (277)

Thyroid Nodules (304)

Diagnosis of Colon Cancer (279)

Treatment of Cervical Lymph Node Tuberculosis (200)

Treatment Experiences for Cervical Lymph Node Tuberculosis (91)

Treatment of Cervical Lymph Node Tuberculosis (251)

Intracranial Tumors (262)

Treatment Experiences for Intracranial Tumors (305)

Ovarian Tumors (458)

A Brief Overview of Ovarian Tumors (468)

A Case of Skin Cancer Cure (377)

A Brief Discussion on Prostate Cancer (510)

A Brief Discussion on Choriocarcinoma (478)

Salamander Cancer (467)

Breast Cancer (267)

Breast Cancer Chemotherapy May Affect Brain Function (520)

Hormone Receptors in Breast Cancer Patients (488)

Treatment Experiences for a Case of Breast Cancer (225)

Soft Tissue Sarcoma (285)

Three-dimensional Conformal Radiation Therapy combined with 5-FU Chemotherapy for Pancreatic Cancer (528)

Treatment Experiences for Neurofibroma (183)

Treatment Experiences for Esophageal Cancer (383)

Esophageal Cancer Herbal Medicine (236)

Esophageal Cancer Treatment Experience (419)

Esophageal Cancer Notes (385)

Treatment of Esophageal Cancer (247)

Pheochromocytoma (259)

Re-understanding of Pheochromocytoma (260)

Diagnosis and Treatment of Pheochromocytoma (267)

Treatment of Advanced Tongue Cancer (157)

Wegener’s Granulomatosis (243)

Wegener’s Granulomatosis (424)

Chemotherapy for Gastric Cancer and Esophageal Cancer (237)

Internal Medicine Treatment for Gastric Cancer (389)

Traditional Chinese Medicine Treatment for Gastric Cancer (311)

Cardiac Myxoma (373)

Cardiac Myxoma (411)

Thymoma (457)

External Treatments for Hemangiomas (325)

Treatment Experiences for Hemangiomas (300)

Inflammatory Pseudotumors (374)

Primary Malignant Lymphoma of the Gastrointestinal Tract (196)

Chemotherapy Regimens for Rectal Cancer (500)

A Case of Successful Treatment of Mediastinal Tumors (32)

Uterine Fibroids and Vaginal Bleeding (391)

Endometrial Cancer and Vaginal Bleeding (390)

Uterine Sarcoma and Vaginal Bleeding (391)

Experience in Treating Mediastinal Tumors (35)

Pediatrics

Bile Retention Jaundice in Infants Aged 2–8 Weeks (463)

Amnold-Chiari Malformation with Spinal Cord Cavitation (389)

Cerebral Palsy (513)

A Brief Account of Cerebral Palsy (402)

Common Tumors in Children (359)

Down Syndrome (438)

High Fever in Children That Does Not Improve (243)

Acute Mesenteric Lymphadenitis in Children (328)

Treatment Experiences for Focal Nephritis in Children (364)

Traditional Chinese Medicine Treatment for Post-Polio Syndrome (405)

Acute Respiratory Infections in Infants (ARI) (527)

Three Major Nutritional Problems Affecting Children’s Growth in China. (478)

Calcitonin-Based Treatment for Diagnosing Neonatal and Pediatric Infections (464)

Gynecology

Several Clinical Issues in Gynecology, ((486)

Treatment Experiences for Women’s Neurosis (6)

Women’s Facial Hot Flashes (448)

Postmenopausal Hormone Therapy (HT) (487)

Pelvic Congestion Syndrome in a Certain Minister (356)

Pelvic Congestion Syndrome (439)

Three Medications for Mastalgia (276)

Traditional Chinese Medicine Treatment for Mastalgia (223)

One Approach to Treating Breast Diseases (169)

Otolaryngology

“Yun Ke Ping” Compound for Inner Ear Dizziness (52)

Cataract Treatment Experiences (160)

Treatment Experiences for Sudden Hearing Loss (136)

Treatment Experiences for Map舌 (243) Case Study on Tinnitus Treatment (430)

On the Treatment of Otogenic Dizziness (416)

The Role of Momordica cochinchinensis in Ophthalmology (109)

Non-Surgical Treatments for Suppurative Otitis Media (84)

Modified Dihuang Decoction for the Treatment of Central Retinal Vein Occlusion (52)

Oral Ulcers Can Lead to Low Fever (314)

Qingre Bu Xue Tang for the Treatment of Oral Inflammation (103)

Treatment of Tongue Cracks (208)

Treatment of Aphasia and Hoarseness (215)

Tianwang Buxin Dan for the Treatment of Chronic Conjunctivitis (82)

Salivary Gland Stones, Also Known as Salivary Calculi (158)

A Case Study on the Treatment of Refractory Oral Ulcers (157)

Wu Zhu Yu Tang for Eye Conditions (101)

Brief Discussion on Dental Diseases (239)

Retinal Hemorrhage (44)

Differentiation and Treatment of Retinal Hemorrhage (129)

Three Cases of Persistent Nasal Bleeding Successfully Treated (21)

Dermatology

Treatment Cases of Alopecia Areata (54)

Treatment of Alopecia Areata ((316)

Treatment of Contagious Molluscum (324)

Liu Duzhou’s Treatment of Blood Wind Eruption (Allergic Dermatitis) (56)

Treatment of Roseola (284)

Traditional Chinese Medicine Treatment of Psoriasis (181)

Three Cases of Skin Disease (159)

Treatment of Urticaria (34)

Qingshang Fangfeng Tang for the Treatment of Common Acne (109)

Treatment Cases of Generalized Itching (402)

Talking About Melasma (28)

Atopic Dermatitis (477)

Persistent Ulcers of the Lower Limbs (55)

Treatment of Psoriasis (482)

Seborrheic Dermatitis (183)

Treatment of Skin Paralysis (85)

Traditional Chinese Medicine Theory

Notes on Differentiation and Diagnosis (24)

The Method of Tonifying Kidney and Subduing Wind for the Treatment of Meniere’s Disease (12)

Discussing the Relationship Between Traditional Chinese Medicine Theory and Western Medicine through the Perspective of Traditional Chinese Medicine (16)

Unit-Based Traditional Chinese Medicine Induces Apoptosis in Tumor Cells (394)

Tonifying the Righteous Qi and Nourishing the Root; Immunity (38)

Gan Wen Xian Run Method (101)

Clinical Applications of Activating Blood Circulation and Removing Stasis (46)

Spleen Deficiency with Yin Fire and the Use of Gan Wen to Clear Heat (62)

Discussion on Spleen Yin Deficiency (107)

Qi Deficiency with Fever and the Use of Gan Wen to Clear Heat (71)

Treatment Cases of Heat-Related Arthritis (58)

Japanese Research on Rehmannia (297)

Japanese Hanfu Community’s Research on Xiao Chai Hu Tang (193)

A Case Study of Laryngitis Treatment (69)

Research on Sanqi (223)

Studies on Tongue Coating (99)

Studies on Tongue Coating (413)

Pharmacological Studies on Musk (191)

Theory of Rising, Descending, Floating, and Falling (105)

Shi Mai Baidu Tang for the Treatment of Unknown Heat (109)

Traditional Chinese Medicine Treatment of Hair Loss (483)

Treatment of Wasting Syndrome (347)

Both External and Internal Cold-Related Diseases Can Be Treated with Xiaohua Dan (299)

Treatment of Deficiency of Middle Qi (214)

Exploration of Research Methods in the Combination of Traditional Chinese and Western Medicine (127)

Classification of Traditional Chinese Medicines and Their Properties (368)

Traditional Chinese Medicine Treatment of Cysticercosis (57)

Classical Works of Traditional Chinese Medicine

Reflections on the Yellow Emperor’s Inner Canon (513)

The Time of Composition of the Yellow Emperor’s Inner Canon (515)

The Effects of Jijiao Lü Huang Wan in the Golden Cabinet (25)

Clinical Applications of Baihu Tang (11)

Clinical Applications of Gui Zhi Fuling Wan (20)

Research on Huanglian Jiedu Tang (141)

Clinical Applications of Huanglian Jiedu Tang (294)

Clinical Experience with Si Ni San (49)

Discussing the Symptoms of Cheng Qi Tang (14)

Discussing the Symptoms of Jie Xiong (9)

Discussing the Symptoms of Xie Xin Tang (10)

The Evolution of the Theory of Warm Disease (358)

Wu Jutong’s Xiangfu Xuanfu Hua Tang (207)

Wu Ling San and Fu Ling Gan Cao Tang (4)

Wu Ling San and Zhu Ling Tang (15)

Experiences with Xie Xin Tang (295)

The Main Symptoms of Yin Chen Hao Tang (216)

Medical Talks and Medical Cases

Ban Yu Kui’s Formula for Treating Psoriasis (148)

Case Studies of Shen Zhen Zhen Qi Tang (382)

Chen Jiadong’s Experience in Treating Dizziness (77)

Chen Xiuyuan’s Modified Si Wu Tang (7)

Cheng Men Xue’s Experience in Treating Insomnia (247)

Fang Mingqian’s Use of Buzhong Yiqi Tang (214)

Gao Huiyuan’s Formula for Treating Behcet’s Disease (199)

Gu Bo Hua’s Four Experiments (155)

Old Chinese Medicine Practitioner Huang Wendong’s Experience in Treating Arrhythmia (32)

Huang Wendong’s Experience in Treating Chronic Bronchitis (33)

Huang Wendong’s Experience in Treating Skin Itching (68)

Huang Wendong’s Treatment for Aplastic Anemia (33)

Father’s Discussion on Nephritis (91)

Father’s Formula for Treating Rheumatoid Arthritis (27)

Father’s Experience in Treating Hypertension (74)

Father’s Experience in Treating Knee Joint Pain (68)

Jia Baozhong’s Case Studies (383)

Reconsideration of Jiang Bi Hua’s Cold-Related Formula (209)

Two Wonderful Formulas from Mr. Jiang Bi Hua (184)

Case Studies by Secretary Zhao of Lanzhou Railway Bureau (387)

Lei Yongzhong’s Formula for Treating Gastric Cancer (472)

Liu He Yi’s Experience (55)

Physician Mao Youfeng’s Method for Treating Wind-Cold-Damp Arthralgia (56)

A Case Study from E’jila Banner, Inner Mongolia (313)

Pu Fuzhou’s Experience (23)

Mr. Pu Fuzhou’s Experience in Treating Hypertension (5)

Qian Bingwen’s Formula for Washing Away Thrombosis-Related Hemorrhoids (228)

Professor Ren Yingqiu’s Experimental Formulas (86)

Japanese Hanfu Experts’ Formulas for Treating Bronchial Asthma (219)

Japanese Herbal Remedies for Stomach and Digestion (293)

Japanese Physicians’ Three Formulas (139)

Xu Songnian’s Experience in Treating Urinary Protein at Shanghai College of Traditional Chinese Medicine (43)

Shang Qidong’s Experience Report (265)

Old Master Shen Zhonggui’s Formula for Treating Ulcerative Disease (22)

Mr. Shi Jinmo’s Anti-Aging and Preventive Formulas (154)

Mr. Shi Jinmo’s Formula for Treating Asthma (212)

Professor Shi Jizhao’s Experience in Treating Liver Disease Combined with Nodular Hyperplasia (391)

Two Case Studies by Shi Zaize (52)

Mr. Wan Xiangchen’s Formula for Treating Thrombocytopenic Purpura (35)

Mr. Wang Fengchun’s Experience in Treating Chest Pain (207)

Mr. Wang xx’s Case Studies (369)

Mr. Wang Weichuan’s Formula for Treating Adrenal Cortex Insufficiency (28)

Mr. Wang Wenzheng’s Experience in Liver Treatment (132)

Mr. Wang Yinqing’s Formula for Liver Treatment (225)

My Father, Mr. Pei Shen,’s Two Formulas for Treating Liver Cirrhosis (115)

My Father’s Experience in Treating Hematuria (324)

Yan Gengfu’s Experience in Treating Coronary Heart Disease (275)

Yan Deqing’s Formula for Treating Vascular Tumors (152)

The Mother of Deputy County Mayor Yang Baozhen (319)

Mr. Yang Limin’s Case Study on Insomnia (318)

Yu Ji Bai’s Treatment for Gastric Prolapse (207)

Old Master Yue’s Treatment for Subcutaneous Nodules (61)

Selected Experiences of Old Chinese Medicine Practitioner Yue Meizhong (58)

Zhang Boyu’s Formula for Treating Pancreatitis (75)

Zhang Xichun’s True Essence of Shen Zhen Zhen Qi Tang (377)

Several Good Formulas from Mr. Zhang Xichun (202)

Mr. Zhang Xichun’s Experience in Treating Vomiting, Nosebleeds, and Hemoptysis (22)

Mr. Zhang Zanchen’s Experience in Treating Tonsil Cancer (294)

Zhao Bingnan’s Clinical Experience in Treating Nodular Erythema (5)

Old Chinese Medicine Practitioner Zhao Xinbo’s Treatment of Brain Development Deficiency (276)

Zhao Xinbo’s Experience in Treating Epilepsy (141)

Zhao Xinbo’s Experience in Treating Post-Traumatic Brain Injury (196)

Zhao Xinbo’s Experience in Treating Radiculitis (196)

Zhao Xiwu’s Experience in Treating Wasting Syndrome (Multiple Neuropathy) (45)

Zhao Xiwu’s Formula for Treating Arthritis (78)

Zhao Xiwu’s Formula for Treating Psoriasis (79)

Zhao Xiwu’s Experience in Treating Urticaria (79)

New Formulas from Zheng Qiao’s Medical Cases (45)

Zheng’s Cangshu Fangji Tang (55)

Zhu Liangchun’s Experience in Treating Arthritis (89)

Zhu Kan Yu’s Experience in Treating Diabetes (70)

Zou Liangcai’s Discussion on the Treatment of Severe Hepatitis (50)

Traditional Chinese Medicine Formulas and Herbs

Two Formulas from “Hong Lu Dian Xue” (251)

Reconsideration of Bujin Compound (211)

Formulas for Dizziness Caused by Arteriosclerosis (70)

Effective Formulas for Hypertension (209)

Guanxin Ning Granules (251)

Formulas Primarily Targeting Lower Blood Pressure to Reduce Hypertension (74)

Jueli Xin Compound (180)

Jueli Guanxin (181)

Kuanxiong Capsules (223)

Formulas for Cerebral Thrombosis (131)

One Formula for Cerebral Thrombosis (94)

Formulas for Thromboangiitis Obliterans (206)

Preparation of Yangxin Pills (211)

A Good Formula for Treating Hypertension-Related Retinal Disease (497)

Another Effective Formula for Treating Coronary Heart Disease (378)

Another Formula for Dizziness Caused by Basilar Arteriosclerosis (431)

Self-Use Yangxin Pills (212)

Beijing College of Traditional Chinese Medicine Cold-Related Formula (84)

Wonderful Formulas for Enlarged Tonsils (361)

Preparation of Jietu Pill (321)

Three Formulas for Senile Emphysema (205)

Comrade Su Ao Zhang from Lixian sent a formula for treating bronchitis (73)

Formulas for Chronic Pharyngitis (86)

Formulas for Chronic Pharyngitis (84)

Preparation of Asthma Capsules (202)

Preparation of Asthma Pills (203)

Formulas for Treating Bronchitis (61)

Two Formulas for Treating Asthma and Chronic Emphysema (210)

New Formulas for Ascariasis of the Biliary Tract (29)

Traditional Chinese Medicine Formulas for Hepatic Encephalopathy (384)

Effective Formulas for Ascites Due to Liver Cirrhosis (146)

Preparation of Liver Cirrhosis Capsules (192)

Another Formula for Chronic Hepatitis (100)

Maintenance Formulas for Chronic Hepatitis (243)

Ten Years of Experience in Treating Chronic Gastritis (519)

Formulas for Stomach Distension and Pain (427)

The Hepatoprotective Effects of Xiao Chai Hu Tang and Chai Hu Saponins (106)

Yibei Kang’s Rejuvenation (316)

Special Formulas for Hepatitis B Treatment (87)

Eight Formulas for Liver Treatment (222)

Chinese Medicine for Treating Gastrointestinal Bleeding (187)

Traditional Chinese Medicine for Treating Hepatitis B (137)

Acute Biliary Infection Formulas from Zunyi Medical College (23)

Formulas for Gynecological and Andrological Inflammation (386)

Additive Yu Lin Zhu (242)

Hanfus Research on Senile Vaginitis (296)

Lianqiao Tang for Blood Urine (142)

Lianzi Qingxin Yin for Urinary Obstruction (80)

Two Effective Formulas for Urinary System Stones (203)

Urinary Stone Formulas (180)

Ran Xue Feng’s Seed Soup (6)

Centipedes as the Main Treatment for Erectile Dysfunction (160)

Erectile Dysfunction Soup with Plum Juice (82)

Internal Formulas for Itching Due to Yin Deficiency (242)

Another Formula for Treating Chronic Kidneys (208).

(Febrile Formulas for Leukemia (308)

Regulating Blood Count (45)

Red and Green Blood-Raising Powder (71)

One Formula for Acute Myeloid Leukemia (159)

One Formula for Chronic Myeloid Leukemia (153)

Several Anti-Leukemia Formulas Currently Available (24)

Five Major White Blood Cell Boosters, Five Major Platelet Boosters (30)

Formulas for Increased Eosinophils (215)

Formulas for Aplastic Anemia (73)

Preparation of Aplastic Anemia Capsules (202)

Aplastic Anemia Formulas (116)

Another Formula for Treating Leukemia (357)

Qingma Chuancao Dan for Treating Chronic Leukemia (190)

Drug Selection for Blood Indicators (173)

Thyroid Hormone Compound (284)

Thyroid Hormone Treatment Formulas ((182)

Thyroid Hormone Treatment Formulas (4)

Diabetes Two Formulas (75)

New Formulas for Diabetes (148)

Gouty Arthritis Formulas (143)

Rheumatoid Arthritis Formulas (182)

One Soup for Rheumatoid Arthritis (151)

Scleroderma Formulas (76)

Commonly Used Traditional Chinese Medicine for Autoimmune Diseases (271)

Rheumatoid Arthritis Formulas (93)

Trigeminal Neuralgia Formulas (32)

Radicular Neuralgia – Fengyin Tang (190)

Two Headache Formulas (386)

Formulas for Treating Epilepsy (88)

Gongguo San (270)

Preparation of Gongguo San (299)

Compound Seven Ingredients White Atractylodes Powder for Trial (221)

The Wonderful Uses of Ganluo Shuikong Dan (183)

Gui Zhi Shaoyao Zhimu Tang – Further Discussion (227)

Huo Xiang Zheng Qi Tang and Jiu Wei Qiang Huo Wan (235)

Several Experienced Formulas (84)

Several Explanatory Formulas (348)

Several Formulas with Certain Clinical Efficacy (13)

Several Clinical Formulas (127)

Several Formulas with Practical Experience (91)

Several Formulas Frequently Used by Japanese Doctors (293)

Several Effective Formulas (3)

Several Effective Formulas (5)

Several Effective Formulas (134)

Jianpi Yiqi Tang combined with Huoxue Hua Yu Tang (284)

Two Good Formulas (360)

Two Experienced Formulas (245)

Two Small Formulas (285)

Qinyu Wan (36)

Preparation of Qingkou Capsules (201)

Clinical Applications of Qinggu San (430)

Qingshang Quan Tong Tang treats all types of headache (9)

Two New Drugs for Hardening and Disintegrating Tumors (34)

Shengyang Yiyi Tang and Wuyao Shunqi San (452)

Four Effective Formulas Introduced (150)

Re-understanding Sifang Yin (290)

Re-understanding Si Ni San (295)

Si Ni San and Huangqi Jianzhong Tang (471)

Si Ni San and Xiangsha Liu Jun Tang (292)

Sisheng Wan (386)

Several Formulas for Renewing the Past and Bringing Out the New (303)

Wuyao Shunqi San (291)

Xiangsheng Po Dian Wan (158)

Xiaofeng Chu Shi Dan (245)

Xiaofeng Chu Shi Dan’s Clinical Trials (250

Xiaoluo Tang – Re-Added Flavor (25)

Research on Nitrate and Fosfate Powder (217)

Nitrate and Fosfate Powder for Treating Pork Cysticercosis (239)

Preparation of Xiaohua Dan (299)

Xiaoning No. 2 (376)

Xiong’s Headache Formula (27)

Xiong’s Spreading Formula (305)

Yi Gan San and Gou Teng San (122)

Comprehensive Formulas (520)

Formulas for Persistent High Fever (292)

High Fever and Traditional Chinese Medicine (108)

Pain in the Groin (53)

Haidou Bujin Wan for Treating Lumbar Pain During Menopause (107)

Weight Loss and Beauty Pills (323)

Jiangsu New Medical College’s Enzyme-Lowering Formula (23)

Formulas for Umbilical Pain (239)

Qiyu Tang for Treating Aphasia (298)

Heat-Related Arthritis Formulas (54)

White Snake and Black Snake (270)

Baiji’s Clinical Applications (278)

Baiji’s Application (206)

The Pharmacological Effects of Bugula (143)

Saffron – A Discussion (287)

Chaihu preparations have glucocorticoid-like effects (141)

Re-understanding Sandalwood (201)

The Application of Insect-Based Medicines in the Treatment of Rheumatoid Arthritis (471)

The Effects of Hedgehog Skin (265)

Dahuang for Treating Chronic Renal Failure (108)

Digongpi and Corn Silk for Reducing Blood Sugar (82)

Dilong’s Clinical Applications (171)

Suan Ye (212)

Research on Dry Lacquer (221)

Hai Hua Fen (275)

Dry Lotus Seed’s Hemostatic Function (29)

He Shou Wu – A Brief Discussion (143)

The Wonderful Uses of Huzhang (30)

Hua Rui Shi’s Hemostatic Effect (213)

Jin Nei Jin’s Further Discussion (274)

Four Traditional Chinese Medicines (406)

The Re-discussion of Suoyang (210)

Weiling Xian – Re-discussion (149)

Weiling Xian’s Functions (146)

The Pharmacological Effects of Wu Zhu Yu (146)

Xixin’s Clinical Applications and Toxicity Reactions (250)

Xia Ku Cao’s Dosage (88)

Xian He Cao’s Functions (146)

Medicinal Plants for Qi Regulation and Warmth in the Middle (333)

A Brief Discussion on Bird’s Egg Plant (403)

Side Effects Caused by Medications in Clinical Practice ((329)

Ye Ming Sha’s Liver-Clearing and Tomorrow-Protecting Effects (81)

Yi Mu Cao and Ma Bian Cao (185)

Further Discussion on Gongying (148) Task output rules: Translate this markdown block from Chinese to English. Preserve markdown markers, links, and formatting. Keep headings and list structure unchanged. Return only the translated block.

Input: Zhe Chong Zhi Ren Jie (271)

Zhi Shi Zhi Xin Yi Fang (173)

Zhong Cao Yao Shen Hai Zai Xiang (394)

Zhong Yao Shao Xi Lei Zhi Yan Gao (99)

Zhong Yao Zhi Ting De Qiang Wei (82)

Zi Cao Zhi Zai Re Jian (286)

Dan Fang Yan Fang

Ban Tu Zhi Xiao Fang ((309))

Bian Ping Wan Zhi Yan Fang (377)

Dai Zhan He Zhi Liang Yan Fang (144)

E Guo Feng Zhi Miao Fang (206)

Tou Dan Ji Zhi Yan Fang. (304)

Ge Ge Zhi Zhi Zhi Cheng Fang (309)

Jiao Qi Zhi Zhi Cheng Fang (187)

Jiu Quan Li Mi Zhi Wei Yao Fen (22)

Li Er Yan Fang (28)

Zhi Liao Zi Gong Qi Zhi Shan Fang (244)

Zhuang Yang Xiao Fang (240)

Xi Yi Ji Chu

ALT He AST Zhi Ke Lin Yi Yi (499)

ALT He AST Zhi Zai Ren Jie " (527)

Bao Chu Zhi Chang Yong Zhi Su Zi (307)

Bao Chu Zhi Ke Lin Diagnosi (345)

CA-50 Ding Zhi Ke Lin Yi Yi (278)

CT Xiang Pi Zhi Yu Jing Dian (436)

Kalcuafrky Ji Bu Zhi (234)

PCR Dian Zhi (302)

PSA He Prostate Bing.. (488)

Rh Jue. (489)

X Guang Pi Zhi Xiao Shi (139)

Cui Mu Zhi Zhi Zhi (266)

Dian Hua Zhi Zhi Zhi Zhi Zhi (414)

Xian Ni Zhi Zhi Zhi Zhi Zhi (460)

Xin Ma Zhi Zhi Zhi Zhi Zhi (427)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi Zhi (427)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (425)

Xin Ma Zhi Zhi Zhi Zhi Zhi (42......Task output rules: Translate this markdown block from Chinese to English. Preserve markdown markers, links, and formatting. Keep headings and list structure unchanged. Return only the translated block.

Input: Zhe Chong Zhi Ren Jie (271)

Zhi Shi Zhi Xin Yi Fang (173)

Zhong Cao Yao Shen Hai Zai Xiang (394)

Zhong Yao Shao Xi Lei Zhi Yan Gao (99)

Zhong Yao Zhi Ting Tong Ji Zhi Kai Wang (82)

Zi Cao Zhi Zai Re Jian (286)

Dan Fang Yan Fang

Ban Tu Zhi Xiao Fang ((309)

Bian Ping Wu Yan Fang (377)

Dai Zhan He Zhi Yan Fang (144)

E Gua Chang Zhi Yan Fang (206)

Tou Dan Qi Zhi Yan Fang. (304)

Ge Jie Zhi Zhi Yan Fang. (309)

Ge Jie Zhi Zhi Yan Fang. (309)

Zhi Gong Qi Zhi Yan Fang. (244)

Zhuang Yang Xiao Fang (240)

Xi Yi Ji Chu

ALT He AST Zhi Ke Lin Yi Yi (499)

ALT He AST Zhi Zai Re Jian " (527)

B Shu Zhi Chang Yong Zhi Su Zi (307)

B Shu Zhi Chang Yong Zhi Su Zi (345)

CA-50 Ze Cun Zhi Ke Lin Yi Yi (278)

CT Ti Xiang Zhi Lue Jing (436)

Kalcuafrky Ji Fen Zhi (234)

PCR Ce Cun (302)

PSA He Qian Li Bing. (488)

Rh Fan Zhi. (489)

X Guang Pi Xiao Shi (139)

Cui Mu Zhi Zhi Xing, (266)

Dian Dian Bu Ji Zhi Xing (442)

Hua Tiao Da Xiang Zhi Xing (414)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian Wei Zhi Xing (460)

Xian...... Task output rules: Translate this markdown block from Chinese to English. Preserve markdown markers, links, and formatting. Keep headings and list structure unchanged. Return only the translated block.

Input: Reading Notes (359)

Reading Short Notes (483)

SARS Records (449)

Small Data on Obesity (491)

Serious Adverse Reactions to Bee Products (474)

Thoughts on Gan Disease Recovery Pill (384)

A Few Small Experiences (254)

A Few Small Communications (490)

A Few Small Data (498)

A Few Small Experiences Worth Promoting (245)

A Few Words (161)

Real-time Records of Several Cases (300)

Several Health Foods (264)

Two Small Experiences (258)

Two Experiences (319)

Two Reflections (327)

Latest Report from Harvard University in the United States (465)

The American Society of Clinical Oncology (ASCO) Announced the Top Ten Advances in Cancer Clinical Research in 2005 (491)

Casual Talks on Nanotechnology (540)

Comprehensive Reports on Japanese Experiences (142)

Three Important Discoveries (534)

Salt and Health (412)

Salmonella Poisoning (429)

A Brief Discussion on Smoking (485)

Small Experiences (254)

Small Forum (327)

Small Data (535)

The Concept of Psychosomatic Diseases (347)

Random Insights from Clinic Visits (86

The Twenty-Four Hours’ Names Used in Ancient Chinese Medical Classics (105)

A Case Consultation at the Main Hospital… (302)

Recent Readings of Several Articles from China Medical Forum (457)

This chapter is prepared for online research and reading; for external materials, please align with original publications and the review process.